These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Bone and joint infection as a predictor of community-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a comparative cohort study. Lee JY; Chong YP; Kim T; Hong HL; Park SJ; Lee ES; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS J Antimicrob Chemother; 2014 Jul; 69(7):1966-71. PubMed ID: 24695351 [TBL] [Abstract][Full Text] [Related]
23. Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections. David MZ; Daum RS; Bayer AS; Chambers HF; Fowler VG; Miller LG; Ostrowsky B; Baesa A; Boyle-Vavra S; Eells SJ; Garcia-Houchins S; Gialanella P; Macias-Gil R; Rude TH; Ruffin F; Sieth JJ; Volinski J; Spellberg B Clin Infect Dis; 2014 Sep; 59(6):798-807. PubMed ID: 24879783 [TBL] [Abstract][Full Text] [Related]
24. Comparison between patients under hemodialysis with community-onset bacteremia caused by community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus strains. Wu HS; Kuo SC; Chen LY; Chiang MC; Lin YT; Wang FD; Fung CP J Microbiol Immunol Infect; 2013 Apr; 46(2):96-103. PubMed ID: 22520272 [TBL] [Abstract][Full Text] [Related]
25. Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus. Falcón R; Mateo E; Oltra R; Giménez E; Albert E; Torres I; Navarro D Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):903-912. PubMed ID: 30729396 [TBL] [Abstract][Full Text] [Related]
26. Epidemiology of bloodstream infections caused by methicillin-resistant Staphylococcus aureus at a tertiary care hospital in New York. Yasmin M; El Hage H; Obeid R; El Haddad H; Zaarour M; Khalil A Am J Infect Control; 2016 Jan; 44(1):41-6. PubMed ID: 26412481 [TBL] [Abstract][Full Text] [Related]
27. Impact of Community-Onset Methicillin-Resistant Bae E; Kim CK; Jang JH; Sung H; Choi Y; Kim MN Ann Lab Med; 2019 Mar; 39(2):158-166. PubMed ID: 30430778 [TBL] [Abstract][Full Text] [Related]
31. Clinical features and risk factors of mortality for bacteremia due to community-onset healthcare-associated methicillin-resistant S. aureus. Lee SC; Lee CW; Shih HJ; Chiou MJ; See LC; Siu LK Diagn Microbiol Infect Dis; 2013 May; 76(1):86-92. PubMed ID: 23420009 [TBL] [Abstract][Full Text] [Related]
35. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2019. Coombs GW; Daley DA; Mowlaboccus S; Pang S; Commun Dis Intell (2018); 2020 Sep; 44():. PubMed ID: 32988337 [TBL] [Abstract][Full Text] [Related]
36. Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia. Mascitti KB; Edelstein PH; Fishman NO; Morales KH; Baltus AJ; Lautenbach E Infect Control Hosp Epidemiol; 2012 Feb; 33(2):160-6. PubMed ID: 22227985 [TBL] [Abstract][Full Text] [Related]
37. Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Jenkins TC; McCollister BD; Sharma R; McFann KK; Madinger NE; Barron M; Bessesen M; Price CS; Burman WJ Infect Control Hosp Epidemiol; 2009 Mar; 30(3):233-41. PubMed ID: 19199535 [TBL] [Abstract][Full Text] [Related]
38. Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study. Ho KM; Robinson JO Anaesth Intensive Care; 2009 May; 37(3):457-63. PubMed ID: 19499868 [TBL] [Abstract][Full Text] [Related]
39. Treatment of community-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: a hospital-based study. Chen LY; Chen LK; Chang CW; Kuo SC; Li LF; Chan YJ; Wang FD Arch Gerontol Geriatr; 2012; 55(1):152-6. PubMed ID: 21820190 [TBL] [Abstract][Full Text] [Related]
40. Staphylococcus aureus bacteremia in an Indian tertiary care hospital: observational study on clinical epidemiology, resistance characteristics, and carriage of the Panton-Valentine leukocidin gene. Eshwara VK; Munim F; Tellapragada C; Kamath A; Varma M; Lewis LE; Mukhopadhyay C Int J Infect Dis; 2013 Nov; 17(11):e1051-5. PubMed ID: 23891294 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]